PIK3CA is a key component of the phosphatidylinositol 3-kinase (PI3K) pathway, and previous studies have confirmed its involvement in tumorigenesis. However, its function and underlying mechanisms in bladder cancer remain largely unclear. Here, researchers used tissue microarray (TMA) technology to perform immunohistochemical staining on tissue samples from 66 bladder cancer patients to detect the expression levels of PIK3CA and CUX1. The results showed that PIK3CA was upregulated in bladder cancer tissues, and patients with high PIK3CA expression had a poorer prognosis. PIK3CA overexpression promoted the growth, migration, invasion, and metastasis of bladder cancer cells, while PIK3CA knockdown had the opposite effect. Gain-of-function and loss-of-function studies demonstrated that CUX1 promotes PIK3CA expression, thereby activating epithelial-mesenchymal transition (EMT), accompanied by the upregulation of Snail, β-catenin, and Vimentin expression and the downregulation of E-cadherin expression in bladder cancer cell lines. Furthermore, CUX1 overexpression could restore the expression levels of Snail, β-catenin, Vimentin, and E-cadherin caused by PIK3CA knockdown. These results indicate that PIK3CA overexpression in bladder cancer is regulated by the transcription factor CUX1, and that PIK3CA exerts its biological function by activating EMT.
In CCK8 and colony formation assays, cell viability and growth were increased in PIK3CA-overexpressing EJ and T24T cells compared to the control group, while cell viability and growth were decreased in PIK3CA-knockdown cells (Figure 1A). In wound healing assays, PIK3CA overexpression promoted the migration of EJ and T24T cells, while PIK3CA knockdown had the opposite effect (Figure 1B). Transwell assays showed that the invasive ability of PIK3CA-overexpressing cells was enhanced, whereas that of PIK3CA-knockdown cells was reduced (Figure 1C). Furthermore, angiogenesis assays also showed similar effects of PIK3CA on angiogenesis in EJ and T24T cells (Figure 1D).
Figure 1. PIK3CA promoted the growth, migration, invasion and angiogenesis of bladder cancer cells in vitro. (Wang Z, et al., 2020)